Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom
Katharina Schwarze, James Buchanan, Jilles M Fermont, et al.
Genetics in Medicine (2019) Vol. 22, Iss. 1, pp. 85-94
Open Access | Times Cited: 194

Showing 1-25 of 194 citing articles:

Conserved pan-cancer microenvironment subtypes predict response to immunotherapy
Alexander Bagaev, Nikita Kotlov, Krystle Nomie, et al.
Cancer Cell (2021) Vol. 39, Iss. 6, pp. 845-865.e7
Open Access | Times Cited: 829
Application of Next Generation Sequencing in Laboratory Medicine
Yiming Zhong, Feng Xu, Jinhua Wu, et al.
Annals of Laboratory Medicine (2020) Vol. 41, Iss. 1, pp. 25-43
Open Access | Times Cited: 160
Clinical Genomics for the Diagnosis of Monogenic Forms of Inflammatory Bowel Disease
Holm H. Uhlig, Fabienne Charbit‐Henrion, Daniel Kotlarz, et al.
Journal of Pediatric Gastroenterology and Nutrition (2020) Vol. 72, Iss. 3, pp. 456-473
Open Access | Times Cited: 104
Unlocking the efficiency of genomics laboratories with robotic liquid-handling
Houriiyah Tegally, James Emmanuel San, Jennifer Giandhari, et al.
BMC Genomics (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 71
Robotics, microfluidics, nanotechnology and AI in the synthesis and evaluation of liposomes and polymeric drug delivery systems
Egor Egorov, Calvin Pieters, Hila Korach-Rechtman, et al.
Drug Delivery and Translational Research (2021) Vol. 11, Iss. 2, pp. 345-352
Open Access | Times Cited: 70
Liquid biopsy in bladder cancer: State of the art and future perspectives
Felice Crocetto, Biagio Barone, Matteo Ferro, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 170, pp. 103577-103577
Closed Access | Times Cited: 68
Next-Generation Sequencing in Newborn Screening: A Review of Current State
Žiga Iztok Remec, Katarina Trebušak Podkrajšek, Barbka Repič Lampret, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 66
Next-Generation Sequencing in Clinical Practice: Is It a Cost-Saving Alternative to a Single-Gene Testing Approach?
Giancarlo Pruneri, Filippo de Braud, Anna Sapino, et al.
PharmacoEconomics - Open (2021) Vol. 5, Iss. 2, pp. 285-298
Open Access | Times Cited: 60
Clinical utility of whole-genome sequencing in precision oncology
Richard Rosenquist, Edwin Cuppen, Reinhard Buettner, et al.
Seminars in Cancer Biology (2021) Vol. 84, pp. 32-39
Closed Access | Times Cited: 59
Implementation of Whole-Genome and Transcriptome Sequencing Into Clinical Cancer Care
Edwin Cuppen, Olivier Elemento, Richard Rosenquist, et al.
JCO Precision Oncology (2022), Iss. 6
Open Access | Times Cited: 54
Metagenomics and artificial intelligence in the context of human health
Atif Khurshid Wani, Priyanka Roy, Vijay Kumar, et al.
Infection Genetics and Evolution (2022) Vol. 100, pp. 105267-105267
Open Access | Times Cited: 49
Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases
Alistair T. Pagnamenta, Carlos Camps, Edoardo Giacopuzzi, et al.
Genome Medicine (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 31
Population screening requires robust evidence—genomics is no exception
Clare Turnbull, Helen V. Firth, Andrew O.M. Wilkie, et al.
The Lancet (2023) Vol. 403, Iss. 10426, pp. 583-586
Closed Access | Times Cited: 29
Genomic diagnosis and care co-ordination for monogenic inflammatory bowel disease in children and adults: consensus guideline on behalf of the British Society of Gastroenterology and British Society of Paediatric Gastroenterology, Hepatology and Nutrition
Jochen Kammermeier, Christopher A Lamb, Kelsey Jones, et al.
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 3, pp. 271-286
Closed Access | Times Cited: 28
Folate and Its Significance in Depressive Disorders and Suicidality: A Comprehensive Narrative Review
Timur Liwinski, Undine E. Lang
Nutrients (2023) Vol. 15, Iss. 17, pp. 3859-3859
Open Access | Times Cited: 28
From the basics to emerging diagnostic technologies: What is on the horizon for tilapia disease diagnostics?
Ha Thanh Dong, Thawatchai Chaijarasphong, Andrew C. Barnes, et al.
Reviews in Aquaculture (2023) Vol. 15, Iss. S1, pp. 186-212
Open Access | Times Cited: 26
Analysis of 10,478 cancer genomes identifies candidate driver genes and opportunities for precision oncology
Ben Kinnersley, Amit Sud, Andrew Everall, et al.
Nature Genetics (2024) Vol. 56, Iss. 9, pp. 1868-1877
Open Access | Times Cited: 13
Benefits for children with suspected cancer from routine whole-genome sequencing
Angus Hodder, Sarah M. Leiter, Jonathan Kennedy, et al.
Nature Medicine (2024) Vol. 30, Iss. 7, pp. 1905-1912
Open Access | Times Cited: 11
Prediction of colorectal cancer microsatellite instability and tumor mutational burden from histopathological images using multiple instance learning
Wenyan Wang, Wei Shi, Chuanqi Nie, et al.
Biomedical Signal Processing and Control (2025) Vol. 104, pp. 107608-107608
Closed Access | Times Cited: 1
Costs of biomarker testing in advanced non‐small cell lung cancer: a global study comparing next‐generation sequencing and single‐gene testing
Umberto Malapelle, Chien‐Chin Chen, Enrique de Álava, et al.
The Journal of Pathology Clinical Research (2025) Vol. 11, Iss. 2
Open Access | Times Cited: 1
Genome‐scale target capture of mitochondrial and nuclear environmental DNA from water samples
Mads Reinholdt Jensen, Eva Egelyng Sigsgaard, Shenglin Liu, et al.
Molecular Ecology Resources (2020) Vol. 21, Iss. 3, pp. 690-702
Open Access | Times Cited: 55
Cancer Biomarkers in the era of precision oncology: Addressing the needs of patients and health systems
Nicola Normanno, Kathi Apostolidis, Francesco De Lorenzo, et al.
Seminars in Cancer Biology (2021) Vol. 84, pp. 293-301
Closed Access | Times Cited: 51
Analytical demands to use whole-genome sequencing in precision oncology
Manja Meggendorfer, Vaidehi Jobanputra, Kazimierz O. Wrzeszczyński, et al.
Seminars in Cancer Biology (2021) Vol. 84, pp. 16-22
Open Access | Times Cited: 41
Cost-effectiveness of genome sequencing for diagnosing patients with undiagnosed rare genetic diseases
Devin Incerti, Xiangming Xu, Jacquelyn W. Chou, et al.
Genetics in Medicine (2021) Vol. 24, Iss. 1, pp. 109-118
Closed Access | Times Cited: 41
Challenges and opportunities associated with rare-variant pharmacogenomics
Yitian Zhou, Roman Tremmel, Elke Schaeffeler, et al.
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 10, pp. 852-865
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top